LRG1 and breast cancer: Some studies are in accordance with the present study that miR‐497 expression was reduced in breast cancer and in multiple myeloma samples and cell lines 19, 20 while LRG1 expression was up‐regulated in hepatocellular carcinoma and in ovarian cancer.21, 22